Streetwise Reports' Article Archives — July 2022 back to current month (69)
Argentina Lithium Active At Salar De Rincon (07/30/2022)
The Critical Investor takes a look at one junior lithium play in Argentina that just had some success with the drill bit and is building its prospective land package — real estate that should only increase in value as lithium carbonate prices hover around US$75,000 per tonne.
Shares of NervGen Pharma Corp. traded 28% higher yesterday after the company reported that, in a landmark pre-clinical animal study, its NVG-291-R demonstrated significant functional repair to damage from ischemic stroke seven days following the event.
Energy industry service company Mammoth Energy Services Inc.'s shares traded 22% higher after the company reported Q2/22 financial results that included significant increases in quarterly revenue, net income, and adjusted EBITDA.
Tenaz Energy Corp. reported it was unsuccessful in obtaining the number of votes needed from SDX Energy Plc.'s shareholders to acquire the company. The firm continues to search for other oil and gas assets to acquire in North Africa and the Middle East that are congruent with its high free cash flow generation strategy. Research Capital Corp. advised in a research note that it is maintaining its Speculative Buy rating and CA$5.00 Target Price on the company.
Val-d’Or Junior Finds Anomalies at MoGold (07/28/2022)
Geophysical surveys often reveal secrets just below the surface. One junior explorer operating in Quebec’s prolific Val d’Or mining camp has found a few of those secrets and it’s ready to drill them to see if a secret or two could become something much more valuable.
Junior Says ESG Is More Than an Acronym (07/28/2022)
This junior is trying new ways to involve the local population in its project, hoping to take “environmental, social, and governance” considerations to a new level.
Junior Hits High-Grade Silver in Colombia (07/28/2022)
Outcrop Silver & Gold Corp., on its way to a maiden resource estimate at its Colombian flagship project, says it has returned its thickest and highest-grade intercepts yet.
A scientist at a junior biotech company recently conducted an additional review of the top line data from a Phase 2a study that used NP-120 to treat idiopathic pulmonary fibrosis (IPF) and chronic cough — only to learn that it treated chronic cough far better than first thought.
Last Thursday, Anixa Biosciences Inc. announced that the USPTO granted an extension for the firm's patented breast cancer vaccine technology. H.C. Wainwright & Co. LLC advised that this action strengthens the company's IP portfolio and therefore it is reiterating its Buy rating on Anixa.
Shares of Northern Dynasty Minerals Ltd. traded more than 22% higher after the Vancouver mining firm reported it entered into a life-of-mine royalty agreement for non-core metals which may provide up to $60 million in proceeds.
Shares of Soligenix Inc. traded 8% higher after the company reported it formed a strategic global partnership to supply SERB Pharmaceuticals with its novel ricin antigen for use in developing a therapeutic treatment against ricin poisoning.
Shares of Zymergen Inc. traded 16% higher after the company reported it agreed to be acquired by Ginkgo Bioworks Inc. in an all-stock transaction valued at $300 million.
Late clinical-stage biopharmaceutical company Cellectar Biosciences Inc. very recently underwent a one for 10 reverse stock split. ROTH Capital Partners LLC advised that it has adjusted its forward projections for the firm and adjusted its 12-month price target to $40/share.
Franco and Royal Make Major Investments (07/25/2022)
Expert Adrian Day discusses recent purchases from two royalty companies, as well as preliminary quarterly reports from several gold companies that he considers top buys right now.
Radiotherapy Co. On-Track With Two Clinical Trials (07/24/2022)
Plus Therapeutics Inc. is developing novel radiotherapy treatments for several rare cancer targets including glioblastoma and leptomeningeal metastases. H.C. Wainwright & Co. advised in a research note that it is reiterating its Buy rating on the company as it expects that upcoming data from two key trials for the firm's RNL-based treatments could provide a major catalyst for the stock in H2/22.
Shares of SANUWAVE Health Inc. traded 12% higher after the company reported it successfully treated legendary football player Jim McMahon Jr. with its ENERGY FIRST system.
electroCore Inc.'s Q2/22 and H1/22 revenues are up quarter over quarter and year over year, respectively, and the upward trend is expected to continue through year-end 2022, noted an H.C. Wainwright & Co. report.
Amazon Makes $3.9B Bid for Virtual Primary Care Co. (07/21/2022)
Shares of One Medical traded nearly 70% higher after the company reported it agreed to be acquired by Amazon Inc. for $18.00 per share in an all-cash deal valued at $3.9 billion.
Biotech Co.'s Phase 3 Trial First to Get Grant (07/20/2022)
A revenue-generating junior biotech company based in the U.K. has become the first public company to be approved for a government grant to fund most of a Phase 3 study exploring the use of psychedelics to treat alcohol use disorder. It could be a catalyst for the share price.
Vancouver-based pharmaceutical development firm Algernon Pharmaceuticals Inc. recently reported topline data from a Phase 2a trial of ifenprodil in IPF patients with chronic cough that met its endpoint and demonstrated promising initial efficacy. Research Capital Corp. advised that it is maintaining its CA$25.00/share price target and "Speculative Buy" rating on the company.
Expert Says the Tide Has Gone Out (07/20/2022)
Expert Michael Ballanger reviews the current market cycle, Elon Musk's impact on the stock market, and reveals the stock he says has a positive outlook amidst the chaotic backdrop of summer 2022.
PolyMet Mining Corp. shares traded nearly 8% higher after the company reported it entered into a joint-venture deal with Teck Resources Ltd. to develop copper, nickel, cobalt, and platinum group metals resources at the NorthMet and Mesaba properties in Minnesota.
These study data from Aldeyra Therapeutics Inc. solidified the therapeutic's path to filing a new drug application, potentially in Q3/22, noted an H.C. Wainwright & Co. report.
Shares of Vimy Resources Ltd. traded 19% higher after the company reported positive results from the first two diamond drill holes at its Alligator River Project in Australia's Northern Territory. The company said it plans to prepare a mineral resource update for its Angularli Deposit in late 2022.
Tectonic Metals Closes CA$2.3M Private Placement (07/19/2022)
The Critical Investor explains why major shareholders like Crescat Capital "are stepping up once again ... but this time increasing their ownership in Tectonic even more" as everyone eagerly awaits the results from Seventymile.
Shares of Sidus Space Inc. traded 37% higher after the satellite technology company reported it has expanded the scope of its working relationship and increased deliverables to Teledyne Technologies Inc. Sidus stated that revenues registered under its contracts with Teledyne in Q2/22 were the highest amounts earned over the course of its four-year relationship with that company.
ScPharmaceuticals Inc. just released topline results from a Phase 2 pilot study supporting the drug developer that is pursuing the expansion of its new drug label, noted an H.C. Wainwright & Co. report.
LIT Lithium Discovery Could Light Up Share Price (07/18/2022)
Lithium carbonate prices are up 340% year-over-year and one lithium junior explorer operating in Argentina just drilled some healthy lithium grades in a salar that extends beyond its property boundary and onto the junior's concessions.
Fundamental Research Corp. mentioned in a research note that this company is on a clear path to a potential new discovery in Argentina. The firm stated that it expects that a maiden resource estimate for its properties will be completed next year and is initiating coverage with a "Buy" rating.
Expert Clive Maund examines the confluence of increasing debt and the precious metals sector and speculates on how the European Central Bank's plan to engage in "unlimited bond buying" will impact the market.
Junior 'Swings for Fences' in Golden Triangle (07/15/2022)
StrikePoint Gold Inc. is "laser-focused" on its Porter Idaho and Willoughby properties in British Columbia's Golden Triangle.
Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with alcohol use disorder (AUD) or alcoholism. One company hopes to bring its treatments to clinics throughout Europe and become the go-to standard of care for AUD.
Shares of Clene Inc. traded 38% higher yesterday after the company reported that its CNM-Au8 was shown to significantly decrease mortality in its RESCUE-ALS long-term extension trial.
Vertical Aerospace Ltd.'s shares traded 70% higher after the eVTOL aircraft designer and manufacturer reported it secured a pre-delivery payment commitment from American Airlines Group for the first 50 units of its VX4 eVTOL aircraft. The firm also advised it received a separate order for 50 VX4s from a business jet operator in Belgium.
One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report.
Green Tech's 'Bugs' to Find Gold in Ecuador (07/14/2022)
This green tech company will use its rock-eating bugs to process gold from mining production in Ecuador—and possibly somewhere near you.
Biopharma Co. Posts 17% BMI Reduction in Ph. 2 Trial (07/14/2022)
Shares of Rhythm Pharmaceuticals Inc. rose by over 30% after the company posted positive interim results from its Phase 2 clinical study of setmelanotide in hypothalamic obesity. The data shows that after 16 weeks of treatment with setmelanotide, patients experienced a 17.2% mean reduction in BMI and a mean weight loss of 15.8%.
Gold Junior Poised for Breakout (07/14/2022)
Technical Analyst Clive Maund explains why this junior gold explorer in Papua New Guinea that is gearing up to go far is a Buy in his book.
One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments.
Milestones Reached at British Columbia Gold Asset (07/13/2022)
At this project in a historical mining district, extensive mine preparations were completed, then mining and processing of placer gold commenced, which "could be a major catalyst for the stock."
Updated PFS May Pave Way to Partnership (07/13/2022)
A simpler open-pit only mine plan for Seabridge Gold’s massive KSM copper-gold project in northern B.C. could attract a joint-venture partner. But it might not be the company you think.
Shares of Canoo Inc. traded 57% higher after the company reported that Walmart has contracted to purchase 4,500 of its electric Lifestyle Delivery Vehicles for use in its growing e-commerce business. The agreement includes an option for 5,500 additional units.
Three Analysts Like Healthcare Co.'s Upside (07/11/2022)
It is difficult to get three people to agree on anything, let alone three investment analysts. But that is precisely the case with one junior biotech company that has shown in a clinical trial that its ketamine-assisted therapy for alcohol use disorder (AUD) is three times more effective than the current standard of care.
Can a psychedelic compound help you heal after a stroke? This biopharmaceutical company hopes it can and plans to start Phase 1 trials this September.
Shares of Volcon Inc. traded 47% after the all-electric powersports company reported that over the course of just 14 days it received thousands of pre-orders for its class-leading 125 hp Stag EV. The orders are expected to provide the firm with an additional $70 million in revenue.
Expert Maurice Jackson sits down with the CEO of Goldshore Resources Inc., Brett Richards to go over the latest updates with the company. With just one year under its belt, Goldshore Resources is already positioning itself to become the next tier one asset in Ontario. The flagship Moss Lake Property has a historical resource with significant expansion potential and is currently undergoing a 100,000-meter drill program, with impressive initial assay results.
Altius Invests in Lara Exploration (07/11/2022)
Expert Adrian Day reviews updates at some of his favorite companies, including most recently the news between Altius Minerals Corp. and Lara Exploration Ltd.'s relationship.
Oil Price Problem? Expert Says Look to 2011 (07/11/2022)
Expert Michael Ballanger reviews this week's updates in the oil and gas sector, specifically his view on the U.S. government's handling of sanctions against Russia and how that will impact the economy.
Albireo Pharma Inc.'s positive Phase 3 trial results indicate the medication would afford patients clinical and quality of life benefits, noted an H.C. Wainwright & Co. report.
New DMD Drug Yields 'Compelling' Data (07/09/2022)
A statistical reanalysis of trial results from Sarepta Therapeutics Inc. shows improved patient function, noted an Oppenheimer report.
Amended Agreement to Benefit Two Biotech Firms (07/08/2022)
In the new arrangement between Beam Therapeutics Inc. and Verve Therapeutics Inc. each of the companies grants the other an exclusive license, one to a base editing target, the other to a gene delivery technology, noted a Wedbush report.
Independent financial analyst Matt Badiali reviews the current bear market in junior mining stocks, profiling Vizsla Silver, Arizona Sonoran Copper Company, and Cross River Ventures Corp. to tell you which stock's risks are worth the reward.
Is KRL the Next K92? (07/07/2022)
This morning, newsletter writer Bob Moriarty, after not writing about a junior mining stock since early June, published an opinion piece on KRL Resources — and came out with a Buy recommendation on the junior.
The agreements include milestone payments based on future revenue from sales of the biopharma Blueprint Medicines Corp.'s therapies, noted a Wedbush report.
Mine Operator Locks In High Copper Prices for 2023 (07/07/2022)
Taseko Mines Ltd.'s shares traded 10% higher after the mine developer and operator reported that last month prior to the recent downturn in raw copper prices it had secured contracts for H1/23 for an additional 30Mlb Cu at prices ranging from $3.75-4.20/lb
As money dries up for a lot of mineral exploration, it seems that investors will still write checks for lithium plays. One junior with two lithium projects in Chile recently raised over $3 million — and the investors approached the company.
The leftist president-elect of Colombia has promised to halt new gas and oil development. But the government has highlighted the importance of finding new forms of energy for the green transition, and one analyst says copper will play a big role in that future.
A green light is expected for the treatment after its developers submit a biologics license application for it, planned for H2/22, noted an H.C. Wainwright & Co. report.
The Critical Investor discusses the first results of deep drilling aimed at the Campbell Shear with CEO Gerald Panneton.
Shares of Ozop Energy Solutions Inc. traded 23% higher after the company reported that H1/22 revenues are expected to be 285% higher versus the same period last year. The firm advised that it anticipates further sequential growth in H2/22.
The FDA Is Expected to Approve New Narcolepsy Drug (07/05/2022)
Avadel Pharmaceuticals Plc., the biopharma company behind this treatment, is currently undervalued and rated Outperform, noted an Oppenheimer report.
The Return of the Northern Peso (07/05/2022)
Expert Michael Ballanger reviews recent movements in the mining and precious metals market and what moves he plans on making as we wait and see whether the Fed will pivot.
What Is the Risk of More Downturn? (07/05/2022)
Expert Adrian Day looks at the state of the market after this year’s 23% decline and discusses the risk of more possible downturn. Find out which companies he thinks are a buy — and which ones need to fly off your radar.
Ra Medical Systems Inc. shares traded 36% higher after the firm reported it received U.S. FDA 510(k) clearance for its DABRA 2.0 Catheter. The DABRA 2.0 is incorporated into the company's DABRA Excimer Laser System which is used by vascular surgeons in procedures to treat lower extremity and peripheral vascular disease.
BC Junior Starts Mining Placer Gold (07/04/2022)
You've seen placer gold being mined on Gold Rush, Discovery's gold mining TV show. But one junior explorer just announced that it's started to commercially mine placer gold in south-central British Columbia from a pay channel underneath Lightning Creek. At least one analyst thinks that makes this junior a Speculative Buy.
In the environment we are now in, the best thing investors can do is find stocks that are impervious to declines in the market indices. Even though they can be hard to find, there are some around, like the one in this story.
The test results bode well for the prefeasibility study of the Canadian explorer's past-producing project in Quebec's historical Val d'Or mining district, noted a Stifel report, and named it the cheapest company in its coverage universe. A Laurentian Bank Securities report called the company's most recent drill results "encouraging."
Trial of New Alzheimer's Drug Slated for Early 2023 (07/01/2022)
The biotech behind this product candidate differentiates itself from competitors with its approach to developing selective antibody therapies, noted an Argus Research Co. report.
Shares of personalized, member-focused healthcare solutions company Accolade Inc. traded 29% higher after the company reported financial results for Q1/23 highlighting a 44% YoY increase in revenue and significant improvements in adjusted gross margin.
|"The news about LIO is all positive."|
|"DEFN looks even more attractive and more of a Buy here than ever."|
|"We are initiating coverage on SEA with an Outperform rating."|
|"+1 Mbbl/d stabilized flow from T100 could be a major catalyst for TAO."|
|"Strong long-term support for DC should turn the price higher again."|